LUXCEL
Desconocido
MetaTox-HS: Advanced Solutions for High Sensitivity Metabolism and Toxicity Assays
LUXCEL BIOSCIENCES LTD
tramitó un
H2020:
H2020-SMEInst-2016-2017
"Drug failure and high development cost (est. €2.3bn/new drug) has driven enormous growth in market need for scientific tests and models of...
2017-07-04 - 2019-05-31 | Financiado
2017-07-04 - 2019-05-31 | Financiado
METACELL-TM: METAbolism analysis made easy for CELL Translational Medicine
LUXCEL BIOSCIENCES LTD
tramitó un
H2020:
H2020-FTIPilot-2016
"The healthcare industry is experiencing unprecedented rates of drug failure, long development times and high costs - because current lab te...
2016-11-17 - 2019-04-30 | Financiado
2016-11-17 - 2019-04-30 | Financiado
PROTECTDAIRY-F2F: Eco innovative and fully integrated microbial rapid monitoring system PROTECTING shelf life food...
LUXCEL BIOSCIENCES LTD
tramitó un
H2020:
H2020-SMEInst-2014-2015
GreenLight® is a ground-breaking new instrument / kit consumable platform to measure microbiological contamination, developed by internation...
2015-11-09 - 2017-11-30 | Financiado
2015-11-09 - 2017-11-30 | Financiado
EXCELL: Exploring Cellular Dynamics at Nanoscale
LUXCEL BIOSCIENCES LTD
participó en un
FP7:
EXCELL is a novel innovative approach to explore interaction mechanisms between biological materials and systems/nanostructures. It involves...
Financiado
Financiado
NANOBIO4TRANS: A new nanotechnology based paradigm for engineering vascularised liver tissue for transplantation
LUXCEL BIOSCIENCES LTD
participó en un
FP7:
Organ transplantation is often the only life saving medical approach for several diseases, in spite of many associated problems (lack of org...
Financiado
Financiado
BIOINTENSE: Mastering bioprocess Integration and intensification across scales
LUXCEL BIOSCIENCES LTD
participó en un
FP7:
BIOINTENSE is directed at addressing the challenges of low productivity and process intensity frequently hampering the implementation of bio...
Financiado
Financiado
OXY-SENSE: OXY SENSE A biosensor image analysis and work flow system platform for the study of neuronal inj...
LUXCEL BIOSCIENCES LTD
participó en un
FP7:
Cellular bioenergetics play a key role in the pathogenesis of acute and chronic neurological disorders. Novel sensors and analytical systems...
Financiado
Financiado
HECATOS: Hepatic and Cardiac Toxicity Systems modelling
LUXCEL BIOSCIENCES LTD
participó en un
FP7:
HeCaToS aims at developing integrative in silico tools for predicting human liver and heart toxicity. The objective is to develop an integra...
Financiado
Financiado
* No se disponen de datos de la empresa actual.